OTC Pharmaceuticals - Hong Kong

  • Hong Kong
  • The OTC Pharmaceuticals market in Hong Kong is projected to generate a revenue of HK US$1,238.00m in 2024.
  • This market is expected to experience an annual growth rate of 6.03% (CAGR 2024-2029).
  • Among the various markets, the Cold & Cough Remedies market holds the largest market share, with a volume of HK US$319.40m in 2024.
  • When compared to other countries, the in the United States leads in revenue generation, with a total of US$41,240.00m in 2024.
  • In terms of per capita figures, in Hong Kong generates HK US$165.10 per person in revenue in 2024.
  • It is also worth noting that online sales are expected to contribute 4.59% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • The demand for OTC Pharmaceuticals in Hong Kong is growing rapidly due to the increasing health consciousness among consumers.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Hong Kong has been experiencing steady growth in recent years, driven by several factors.

Customer preferences:
In Hong Kong, customers have shown a growing preference for over-the-counter (OTC) pharmaceuticals due to their convenience and accessibility. With a busy lifestyle and limited time for doctor visits, many consumers are turning to OTC medications for self-treatment of minor ailments. Additionally, the increasing awareness and knowledge about various health conditions have empowered consumers to make informed decisions about their healthcare needs, leading to a higher demand for OTC products.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Hong Kong is the rising demand for natural and herbal remedies. Consumers are increasingly seeking alternatives to traditional pharmaceutical products, preferring natural ingredients and holistic approaches to healthcare. This trend can be attributed to a growing interest in wellness and preventive healthcare, as well as concerns about the potential side effects of synthetic medications.Another trend in the market is the increasing availability of OTC medications through online platforms. E-commerce has gained significant popularity in Hong Kong, offering consumers the convenience of purchasing OTC products from the comfort of their homes. Online platforms also provide a wider range of products and competitive pricing, attracting a larger customer base.

Local special circumstances:
One of the unique aspects of the OTC Pharmaceuticals market in Hong Kong is the influence of traditional Chinese medicine (TCM). TCM has a long history in Hong Kong and is deeply rooted in the local culture. Many consumers in Hong Kong prefer TCM remedies for certain health conditions, such as cold and flu, digestive issues, and pain management. This preference for TCM products alongside Western OTC medications creates a diverse market with a wide range of options for consumers.

Underlying macroeconomic factors:
Several macroeconomic factors contribute to the growth of the OTC Pharmaceuticals market in Hong Kong. The city's aging population is one such factor, as older individuals often require more medications for chronic conditions and health maintenance. Additionally, Hong Kong's high population density and urban lifestyle contribute to the spread of common ailments, such as colds and allergies, leading to an increased demand for OTC medications.Furthermore, the government's efforts to promote self-care and reduce healthcare costs have also played a role in the growth of the OTC Pharmaceuticals market. The government encourages individuals to take responsibility for their own health and provides education on self-treatment options. This approach aligns with the preferences of consumers who seek convenience and cost-effective solutions for minor health issues.In conclusion, the OTC Pharmaceuticals market in Hong Kong is experiencing growth due to customer preferences for convenience and accessibility, the rising demand for natural and herbal remedies, the increasing availability of OTC medications through online platforms, the influence of traditional Chinese medicine, and underlying macroeconomic factors such as an aging population and government initiatives to promote self-care.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)